These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 7712685)

  • 1. Long term use of captopril or nifedipine in normotensive microalbuminuric patients with insulin-dependent diabetes mellitus.
    Bilo H; Kluitman E; van Ballegooie E; Potter van Loon BJ; Bakker K; Michels B; Gans R; Donker A
    Diabetes Res; 1993; 23(3):115-22. PubMed ID: 7712685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Albuminuria induced by exercise in hypertensive type I and type II diabetic patients: a randomised, double-blind study on the effects of acute administration of captopril and nifedipine.
    Romanelli G; Giustina A; Cravarezza P; Caldonazzo A; Agabiti-Rosei E; Giustina G
    J Hum Hypertens; 1991 Jun; 5(3):167-73. PubMed ID: 1920340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of effect of captopril on glomerular hyperfiltration in normoalbuminuric normotensive insulin-dependent diabetic patients.
    de Azevedo MJ; Ramos OL; Gross JL
    Horm Metab Res; 1997 Oct; 29(10):516-9. PubMed ID: 9405980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal responses to nifedipine and captopril in hypertensive insulin-dependent diabetic men: a randomized cross-over study.
    Jenkins DA; Cowan P; Patrick AW; Clarke BF
    Nephrol Dial Transplant; 1993; 8(3):200-5. PubMed ID: 8385284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effect of captopril and nifedipine in normotensive patients with incipient diabetic nephropathy.
    Insua A; Ribstein J; Mimran A
    Postgrad Med J; 1988; 64 Suppl 3():59-62; discussion 90-2. PubMed ID: 3074298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term renoprotection by perindopril or nifedipine in non-hypertensive patients with Type 2 diabetes and microalbuminuria.
    Jerums G; Allen TJ; Campbell DJ; Cooper ME; Gilbert RE; Hammond JJ; O'Brien RC; Raffaele J; Tsalamandris C;
    Diabet Med; 2004 Nov; 21(11):1192-9. PubMed ID: 15498085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of captopril on ambulatory blood pressure, renal and cardiac function in microalbuminuric type 1 diabetic patients.
    Hansen KW; Klein F; Christensen PD; Sørensen K; Andersen PH; Møller J; Pedersen EB; Christiansen JS; Mogensen CE
    Diabete Metab; 1994; 20(5):485-93. PubMed ID: 7859897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term administration of captopril and nifedipine and exercise-induced albuminuria in normotensive diabetic patients with early-stage nephropathy.
    Romanelli G; Giustina A; Bossoni S; Caldonazzo A; Cimino A; Cravarezza P; Giustina G
    Diabetes; 1990 Nov; 39(11):1333-8. PubMed ID: 2227107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of lisinopril on progression of retinopathy and microalbuminuria in normotensive subjects with insulin-dependent diabetes mellitus].
    Sjølie AK; Chaturvedi N; Fuller J
    Ugeskr Laeger; 1999 Feb; 161(7):949-52. PubMed ID: 10051804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal protection and angiotensin converting enzyme inhibition in microalbuminuric type I and type II diabetic patients.
    Cooper ME
    J Hypertens Suppl; 1996 Dec; 14(6):S11-4. PubMed ID: 9023709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study.
    Ravid M; Lang R; Rachmani R; Lishner M
    Arch Intern Med; 1996 Feb; 156(3):286-9. PubMed ID: 8572838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Beneficial effect of the ACE inhibitor captopril in normotensive patients with insulin-dependent diabetes].
    Cziráki A; Rinfel J; Hunyady B; Nagy S; Mezey B; Jávor T; Schmidt E; Nemessányi Z; Mózsik G
    Orv Hetil; 1998 Sep; 139(39):2307-11. PubMed ID: 9789984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term effect of a chicken-based diet versus enalapril on albuminuria in type 2 diabetic patients with microalbuminuria.
    de Mello VD; Zelmanovitz T; Azevedo MJ; de Paula TP; Gross JL
    J Ren Nutr; 2008 Sep; 18(5):440-7. PubMed ID: 18721739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term treatment with nifedipine reduces urinary albumin excretion and glomerular filtration rate in normotensive type 1 diabetic patients with microalbuminuria.
    Schnack C; Capek M; Banyai M; Kautzky-Willer A; Prager R; Schernthaner G
    Acta Diabetol; 1994 Apr; 31(1):14-8. PubMed ID: 8043891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of captopril therapy on the degree of microalbuminuria in diabetic children and adolescents with incipient nephropathy].
    Barkai L; Soós A; Vámosi I
    Orv Hetil; 1996 Nov; 137(46):2565-8. PubMed ID: 9005384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary epidermal growth factor excretion is correlated to renal function loss per se and not to the degree of diabetic renal failure.
    ter Meulen CG; Bilo HJ; van Kamp GJ; Gans RO; Donker AJ
    Neth J Med; 1994 Jan; 44(1):12-7. PubMed ID: 8202200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitrendipine and enalapril improve albuminuria and glomerular filtration rate in non-insulin dependent diabetes.
    Mosconi L; Ruggenenti P; Perna A; Mecca G; Remuzzi G
    Kidney Int Suppl; 1996 Jun; 55():S91-3. PubMed ID: 8743521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term suppression of elevated growth hormone concentrations following insulin-like growth factor 1 administration in young adults with type 1 diabetes does not alter glomerular filtration or albumin excretion rates.
    Williams RM; Yuen K; White D; Mallard B; Dalton RN; Acerini CL; Dunger DB
    Clin Endocrinol (Oxf); 2006 Oct; 65(4):439-45. PubMed ID: 16984235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating endothelin-1 levels in lean non-insulin-dependent diabetic patients. Influence of ACE inhibition.
    Ferri C; Laurenti O; Bellini C; Faldetta MR; Properzi G; Santucci A; De Mattia G
    Am J Hypertens; 1995 Jan; 8(1):40-7. PubMed ID: 7734095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The significance of deletion polymorphism in the ACE gene for progression of diabetic nephropathies treated with ACE inhibitors].
    Tarnow L; Parving HH; Jacobsen P; Rossing P; Lecerf L; Poirier O; Cambien F
    Ugeskr Laeger; 1998 Aug; 160(34):4886-9. PubMed ID: 9741257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.